News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Approves GE Healthcare’s SenoBright Spectral Mammography Device
October 17, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography unit.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Approvals
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
August 31, 2026
·
2 min read
·
Tristan Manalac
FDA
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro
August 28, 2026
·
2 min read
·
Heather McKenzie
Approvals
Priovant nabs first FDA approval for targeted tablet in dermatomyositis
August 28, 2026
·
2 min read
·
Tristan Manalac
Cancer
RevMed could become ‘next oncology titan’ with Rasonque nod
August 27, 2026
·
2 min read
·
Tristan Manalac